# Starling Oncology, Inc.: filings

STLN · Nasdaq · CIK 1799191 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stln.md) · [Financials](/companies/stln/financials.md) · [Filings](/companies/stln/filings.md) · [Insiders](/companies/stln/insiders.md)

## Reports and events: 146 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 216, 8-K 79, 3 31, 424B3 26, 10-Q 20, 4/A 17, 144 15, EFFECT 11, SC 13G/A 11, CORRESP 10, SC 13D/A 9, SC 13G 8, UPLOAD 8, 10-K 6, DEFA14A 6, DEF 14A 5, SCHEDULE 13D/A 5, 10-K/A 4, 425 4, 8-K/A 4, POS AM 4, S-1 4, S-1/A 4, SC 13D 4, ARS 3, S-4/A 3, SCHEDULE 13G/A 3, 10-Q/A 2, 3/A 2, 424B5 2, D 2, PRE 14A 2, S-3 2, S-8 2, 25-NSE 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, NT 10-Q 1, S-3/A 1, S-4 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-02 | 20:41 ET | [8-K](/filings/0001079973-26-001208.md) | 5.02 Departure or appointment of officers or directors | 0001079973-26-001208 |
| 2026-08-21 | 17:25 ET | [8-K](/filings/0001079973-26-001169.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001079973-26-001169 |
| 2026-08-06 | 16:36 ET | [10-Q](/filings/0001799191-26-000017.md) | Quarterly report, period 2026-06-30 | 0001799191-26-000017 |
| 2026-08-06 | 16:32 ET | [8-K](/filings/0001079973-26-001006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-001006 |
| 2026-08-03 | 09:00 ET | [8-K](/filings/0001079973-26-000997.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-000997 |
| 2026-07-07 | 17:00 ET | [8-K](/filings/0001079973-26-000934.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-000934 |
| 2026-06-18 | 16:30 ET | [8-K](/filings/0001553350-26-000093.md) | 5.07 Shareholder vote results | 0001553350-26-000093 |
| 2026-05-22 | 16:30 ET | [8-K](/filings/0001079973-26-000721.md) | 1.05 Material cybersecurity incident; 9.01 Financial statements and exhibits | 0001079973-26-000721 |
| 2026-05-15 | 16:30 ET | [SCHEDULE 13D/A](/filings/0001213900-26-057832.md) | Ownership report, active investor, amended | 0001213900-26-057832 |
| 2026-05-07 | 16:12 ET | [8-K](/filings/0001079973-26-000611.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-000611 |
| 2026-05-07 | 16:11 ET | [10-Q](/filings/0001799191-26-000010.md) | Quarterly report, period 2026-03-31 | 0001799191-26-000010 |
| 2026-04-30 | 16:16 ET | [DEF 14A](/filings/0001193125-26-197350.md) | Proxy statement, period 2026-06-17 | 0001193125-26-197350 |
| 2026-03-13 | 17:16 ET | [8-K](/filings/0001079973-26-000304.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-000304 |
| 2026-03-12 | 16:56 ET | [10-K](/filings/0001799191-26-000007.md) | Annual report, period 2025-12-31 | 0001799191-26-000007 |
| 2026-03-12 | 16:05 ET | [8-K](/filings/0001079973-26-000291.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-000291 |
| 2026-02-23 | 16:44 ET | [8-K](/filings/0001553350-26-000007.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001553350-26-000007 |
| 2026-01-12 | 08:00 ET | [8-K](/filings/0001079973-26-000068.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-26-000068 |
| 2026-01-07 | 17:02 ET | [8-K](/filings/0001079973-26-000051.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-26-000051 |
| 2025-12-01 | 16:30 ET | [8-K](/filings/0001553350-25-000168.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001553350-25-000168 |
| 2025-11-20 | 16:01 ET | [SCHEDULE 13D/A](/filings/0001213900-25-113108.md) | Ownership report, active investor, amended | 0001213900-25-113108 |
| 2025-11-14 | 06:18 ET | [8-K](/filings/0001079973-25-001724.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-001724 |
| 2025-11-13 | 16:19 ET | [10-Q](/filings/0001799191-25-000036.md) | Quarterly report, period 2025-09-30 | 0001799191-25-000036 |
| 2025-11-13 | 16:06 ET | [8-K](/filings/0001079973-25-001707.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-001707 |
| 2025-11-06 | 16:30 ET | [8-K](/filings/0001079973-25-001666.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-001666 |
| 2025-09-05 | 16:05 ET | [SCHEDULE 13D/A](/filings/0001213900-25-085013.md) | Ownership report, active investor, amended | 0001213900-25-085013 |
| 2025-08-13 | 17:12 ET | [10-Q](/filings/0001628280-25-040225.md) | Quarterly report, period 2025-06-30 | 0001628280-25-040225 |
| 2025-08-13 | 16:21 ET | [8-K](/filings/0001079973-25-001264.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-001264 |
| 2025-08-13 | 16:16 ET | [8-K](/filings/0001079973-25-001263.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-001263 |
| 2025-05-19 | 17:07 ET | [8-K](/filings/0001079973-25-000905.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-000905 |
| 2025-05-14 | 16:25 ET | [8-K](/filings/0001079973-25-000800.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-000800 |
| 2025-05-14 | 16:23 ET | [10-Q](/filings/0001628280-25-025507.md) | Quarterly report, period 2025-03-31 | 0001628280-25-025507 |
| 2025-05-08 | 16:55 ET | [8-K](/filings/0001079973-25-000774.md) | 5.07 Shareholder vote results | 0001079973-25-000774 |
| 2025-05-07 | 16:30 ET | [8-K](/filings/0001079973-25-000764.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001079973-25-000764 |
| 2025-04-23 | 18:20 ET | [SCHEDULE 13D/A](/filings/0001104659-25-038121.md) | Ownership report, active investor, amended | 0001104659-25-038121 |
| 2025-04-11 | 08:30 ET | [8-K](/filings/0001079973-25-000610.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001079973-25-000610 |
| 2025-03-28 | 20:55 ET | [SCHEDULE 13D/A](/filings/0001013762-25-004366.md) | Ownership report, active investor, amended | 0001013762-25-004366 |
| 2025-03-27 | 06:06 ET | [8-K](/filings/0001079973-25-000486.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001079973-25-000486 |
| 2025-03-27 | 06:05 ET | [DEF 14A](/filings/0001193125-25-064588.md) | Proxy statement, period 2025-05-07 | 0001193125-25-064588 |
| 2025-03-26 | 18:55 ET | [10-K](/filings/0001799191-25-000014.md) | Annual report, period 2024-12-31 | 0001799191-25-000014 |
| 2025-03-25 | 06:05 ET | [8-K](/filings/0001079973-25-000460.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-000460 |
| 2025-03-24 | 07:17 ET | [8-K](/filings/0001079973-25-000450.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-000450 |
| 2025-03-24 | 07:00 ET | [8-K](/filings/0001079973-25-000446.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001079973-25-000446 |
| 2025-02-26 | 16:31 ET | [8-K](/filings/0001079973-25-000324.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001079973-25-000324 |
| 2024-12-19 | 17:22 ET | [8-K](/filings/0001079973-24-001742.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001079973-24-001742 |
| 2024-11-13 | 16:33 ET | [10-Q](/filings/0001799191-24-000030.md) | Quarterly report, period 2024-09-30 | 0001799191-24-000030 |
| 2024-11-13 | 16:06 ET | [8-K](/filings/0001799191-24-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001799191-24-000028 |
| 2024-11-12 | 06:04 ET | [8-K](/filings/0001079973-24-001491.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001079973-24-001491 |
| 2024-09-23 | 09:00 ET | [8-K](/filings/0001553350-24-000088.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001553350-24-000088 |
| 2024-08-20 | 08:20 ET | [SC 13D/A](/filings/0001193125-24-203246.md) | Ownership report, active investor, amended | 0001193125-24-203246 |
| 2024-08-13 | 16:17 ET | [10-Q](/filings/0001799191-24-000022.md) | Quarterly report, period 2024-06-30 | 0001799191-24-000022 |

Page 1 of 3. [Older](/companies/stln/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.